Pfizer exits GSK majority-owned ViiV Healthcare; Shionogi raises stake
Pfizer (PFE) has decided to divest its equity holding in ViiV Healthcare, an HIV treatment maker majority owned by GSK...
Tag: PFE
RFK Jr. has reportedly removed four members of vaccine injury panel
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has dismissed at least four of the Advisory Commission on...
Novavax rises after licensing deal with Pfizer
Novavax (NVAX) shares added ~5% in the premarket on Tuesday after the COVID-19 vaccine maker reached a licensing deal with...
Pfizer seeking priority voucher from Trump administration – report
Pfizer (PFE) has been in talks with the Trump administration to receive a priority voucher under a new FDA pilot program...
Pfizer’s BRAFTOVI combination boosts response rates in metastatic colorectal cancer
Pfizer (PFE) reported positive findings from Cohort 3 of the pivotal BREAKWATER trial, a separate randomized cohort...
Pfizer inks licensing deal with Madrigal for MASH candidate
Madrigal Pharmaceuticals (MDGL) announced on Friday an exclusive global license agreement with Pfizer (PFE) for ervogastat,...
Pfizer collaborating with Boltz to use AI models for drug discovery
Pfizer (PFE) has entered into an agreement with Boltz to use the latter's biomolecular AI foundation models to tap into the...
Pfizer reports patient death in hemophilia trial for Hympavzi
Pfizer (PFE) on Tuesday announced that a patient who was taking part in a long-term extension trial for its hemophilia...
Bristol-Myers blood thinner Eliquis offered free to Medicaid as part of U.S. pricing deal
The U.S. government struck drug pricing deals with nine leading drugmakers on Friday, with the most notable among them being...
AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters
Leading drugmakers, including AbbVie (ABBV), Bristol Myers Squibb (BMY), Gilead (GILD), and Merck (MRK), will be among the...